A Trial to Learn if REGV131-LNP1265 is Safe and Works to Help the Body Make Clotting Factor in Pediatric, Adolescent and Adult Patients With Hemophilia B
Conditions: Hemophilia B Interventions: Drug: REGV131; Drug: LNP1265 Sponsors: Regeneron Pharmaceuticals; Intellia Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Haemophilia | Hemophilia | Learning | Pediatrics | Research | Universities & Medical Training